Home › Cancer (all types) › Texas
Cancer (all types) clinical trials in Texas
186 studies for Cancer (all types) are looking for participants at sites in Texas.
Cities in Texas
- Houston123 studies
- San Antonio41 studies
- Dallas38 studies
- Austin21 studies
- Irving16 studies
- Fort Worth10 studies
- Tyler7 studies
- League City6 studies
- The Woodlands5 studies
- Killeen5 studies
- El Paso4 studies
- Richardson3 studies
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06881992A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
- MD Anderson Cancer Center, Houston
- South Texas Accelerated Research Therapeutics (START), San Antonio
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06884618Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
- Dell Seton Medical Center at The University of Texas, Austin
- University of Texas at Austin, Austin
- Parkland Memorial Hospital, Dallas
- and 10 more
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 28, 2026 · NCT05256225A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
- NEXT Oncology, Austin
- NEXT Oncology, Dallas
- SCRI at Mary Crowley, Dallas
- and 3 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07612176A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
- and 3 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06989437First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
- GSK Investigational Site, San Antonio
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07438782Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
- The University of Texas M. D. Anderson Cancer Center, Houston
Recruiting
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06667427A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Oncology Consultants PA, Houston
- University of Texas MD Anderson Cancer Center, Houston
- US Oncology Research Investigational Products Center, Irving
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 25, 2026 · NCT05920356A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06150157Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
- NEXT Oncology ( Site 0151), San Antonio
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07600749A Study of JNJ-1761981 in Participants With Solid Tumors
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07525141A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06311578A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
- Baylor College of Medicine Medical Center ( Site 0004), Houston
- Harris Health System ( Site 0040), Houston
- Mays Cancer Center ( Site 0039), San Antonio
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06979596A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- University of Texas M.D. Anderson Cancer Center ( Site 4007), Houston
RecruitingPhase 1/2
1 Month – 17 Years · All sexes · Updated Sep 25, 2026 · NCT07630974A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
- GSK Investigational Site, Dallas
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07277270A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Texas Oncology-Baylor Charles A Sammons Cancer Center, Dallas
- The Center For Cancer And Blood Disorders (Texas Cancer Care), Fort Worth
- Houston Methodist Cancer Center, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06901531A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- The University of Texas MD Anderson Cancer Center /ID# 280070, Houston
- Texas Oncology - Northeast Texas /ID# 280642, Tyler
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07365241Intratumoral N17350 in Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07339176Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 6, Houston
RecruitingPhase 3
Ages 18 to 71 · All sexes · Updated Sep 23, 2026 · NCT07504458Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
- START San Antonio ( Site 0104), San Antonio
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07405164TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- The University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 22, 2026 · NCT02693535Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- MD Anderson, Houston
- NEXT Dallas, Irving
- NEXT Oncology San Antonio, San Antonio
- and 1 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551Prospective Study to Assess a Diagnostic Aid for Cancer
- Premier Family Physicians, Austin
- Texas Digestive, Harlingen
- Huntsville Research Institute, LLC, Huntsville
- and 1 more
RecruitingObservational study
Ages 45 and older · All sexes · Updated Sep 21, 2026 · NCT07046260Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Texas Oncology, Dallas
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
- UT Southwestern Medical Center, Dallas
- and 3 more
RecruitingPhase 2/3
All ages · All sexes · Updated Sep 18, 2026 · NCT03435796Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.
- M D Anderson Cancer Center, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05694650Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
- UT MD Anderson Cancer Center, Houston
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT07743476A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- University of Texas-MD Anderson Cancer Center ( Site 3007), Houston
RecruitingPhase 1/2
1 Month – 17 Years · All sexes · Updated Sep 17, 2026 · NCT06941272Connect for Cancer Prevention Study (Connect)
- Baylor Scott and White Health, Dallas
RecruitingObservational studyHealthy volunteers welcome
Ages 30 to 70 · All sexes · Updated Sep 17, 2026 · NCT04609072REC-7735 in Participants With Solid Tumors
- NEXT Oncology - Dallas, Irving
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07819136A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
- NEXT Dallas, Irving
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07578571Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- UT Southwestern Medical Center, Dallas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05796375Statins to Prevent Cancer Associated Blood Clots
- The University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07303816REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
- El Paso Medical Research Institute (Medresearch Inc), El Paso
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07410117(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- The University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04996875RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Dell Medical School, University of Texas at Austin, Austin
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
- The University of Texas M. D. Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT06807593A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- University of Texas - Southwestern Medical Center /ID# 271914, Dallas
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT06953960A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Houston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT05123482A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
- Houston Methodist Hospital ( Site 0103), Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07030712Falcon Real World Evidence Registry
- Baylor Scott & White Health, Dallas
RecruitingObservational studyHealthy volunteers welcome
Ages 50 to 80 · All sexes · Updated Sep 11, 2026 · NCT06589310From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.